Jeffrey Tice

Jeffrey Tice, MD, is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. His academic and clinical work is focused on breast cancer risk assessment, prevention, and screening, as well as health policy and cost-effectiveness analysis of medical interventions.

Education:

• BA in Mathematics / Philosophy, Dartmouth College (1983)
• M.D., University of California, San Francisco (1994)
• Residency, University of California, San Francisco (1997)
• Clinical Research Fellowship, University of California, San Francisco (1999)
• Diversity, Equity, and Inclusion Champion Training, UCSF (2022)

Dr. Tice’s research interests include breast cancer risk assessment, prevention, and screening, as well as evidence-based medicine, value in medicine, and nutrition. He develops and evaluates risk models to improve early detection and preventive strategies. His work integrates epidemiology, clinical decision-making, and health economics to reduce the burden of breast cancer. He also contributes to national clinical guidelines, particularly through the American College of Physicians.

His recent publications span topics such as breast cancer screening technologies (e.g., digital breast tomosynthesis), cost-effectiveness of gene therapies, pharmacologic treatments for migraine and depression, and osteoporosis management. The articles reflect a strong focus on clinical guidelines, preventive medicine, and health economics, with frequent collaboration on large-scale simulation and meta-analytic studies.

Scientific Awards:

• SF Bay Area Top Doctor (2015–2023)
• Alpha Omega Alpha, UCSF (2004)
• Phi Beta Kappa, Dartmouth College (1983)

Dr. Tice actively contributes to advising and grant-funded research, particularly through his role at the Institute for Clinical and Economic Review (ICER), where he supports technology assessments and value-based healthcare evaluations. He has been involved in numerous studies assessing the cost-effectiveness of new drugs, devices, and health system interventions. His work often informs policy and clinical practice, especially in preventive oncology and chronic disease management.

He is affiliated with the Institute for Global Health Sciences at UCSF and focuses on guideline development, oncology, and women’s health. His expertise bridges clinical medicine, epidemiology, and health policy, making him a key contributor to evidence-based practice and value-driven care.